For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...

We reviewed hundreds of skin care and makeup products to bring you the best of Shop TODAY's 2024 Beauty Awards. From skin ...

Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes ...

Sana Biotechnology’s innovative approach to treating type 1 diabetes centers around its HIP-modified pancreatic islet cell transplant. In the context of type 1 diabetes, the body’s immune system ...

Stock futures were mixed in the premarket hours of Wednesday, driven by the resurgence of inflation concerns in the U.S. Here ...

Sana Biotechnology (SANA) announced initial results from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared ...

Late consumption of calories is associated with worse glucose tolerance, according to a study published online Oct. 2 ...

Lucknow: Contrary to the popular belief that black coffee and green team contract blood sugar and improve insulin sensitivity, doctors at King George'.

People with type 2 diabetes who are using Ozempic are more likely to develop damage to the optic nerve of the eye compared to ...